JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
MRKR - Marker Therapeutics, Inc.
USD | NASDAQ | Healthcare
Summary
Summary MRKR Stock
Financials
Financials MRKR Stock
Loading...
Loading...
Income Statement
Income Statement MRKR Stock
Balance Sheet
Balance Sheet MRKR Stock
Cash Flow Statement
Cash Flow Statement MRKR Stock
Loading...
Loading...
MRKR Financials - Marker Therapeutics Income & Cash Flow | Ledgeburg
Home
Stocks
Marker Therapeutics, Inc. (MRKR)
Financials
Financials of MRKR
Loading...
Loading...
Loading...
Loading...
Revenue
$3.546669M
Operating Income
$-12.890426M
Net Income
$-12.16362M
Share Count (Basic)
15.310308M
Operating Cash Flow
$-12.014081M
Free Cash Flow
N/A
Cash And Short-Term Equivalents
$16.068048M
Total Debt
N/A
Annual
Quarterly
Revenue $USD
0
2M
4M
6M
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue $USD
0
500K
1M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
Annual
Quarterly
Net Income $USD
-40M
-30M
-20M
-10M
Annual
Quarterly
Margins
Gross
Operating
Net
-800%
-600%
-400%
-200%
FY2021
FY2022
FY2023
FY2024
FY2025
Net Income $USD
-4M
-3M
-2M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
FY2021
FY2022
FY2023
FY2024
FY2025
Margins
Gross
Operating
Net
-1500%
-1000%
-500%
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26